UNITED STATES DISTRICT COURT

FOR THE DISTRICT OF COLUMBIA

WILLIAM T. MORRISON, JR.,

Plaintiff,

v. 

FEDERAL BUREAU OF PRISONS,

Defendant. 

Case No. 19-cv-1838 (CRC)

MEMORANDUM OPINION

Federal inmate William T. Morrison, Jr., proceeding pro se, filed suit alleging that the 

Federal Bureau of Prisons (“BOP”) has mismanaged the treatment of his high cholesterol. He 

requests a declaratory judgment stating that he is entitled to receive the nutritional supplement 

Coenzyme Q10 (“CoQ10”) as part of his treatment. Although Morrison’s Amended Complaint 

is somewhat unclear, the Court construes his claim as challenging his treatment under the Eighth 

Amendment of the Constitution. The government has moved to dismiss on the merits and on 

mootness grounds. Alternatively, it seeks a transfer of venue to the district where Morrison was 

incarcerated when he filed suit. The Court rejects the government’s mootness and venue 

arguments. But because Morrison has not alleged facts showing that BOP acted with deliberate 

indifference to his medical needs, the Court will dismiss the case for failure to state an Eighth 

Amendment violation. 

I. Background

Mr. Morrison has been in BOP custody since February 2016. Am. Comp. at ¶9. When 

he filed this suit in June 2019, he was housed at FCI Elkton in Ohio. Id. at 12. He now resides 

at FCI El Reno in Oklahoma. See Notice of Change of Address, ECF. Dkt. No. 35. According 
2

to Morrison’s December 2019 Amended Complaint–––which the Court must accept as true at 

this stage of the proceedings–––he has “a . . . family history of coronary heart disease, 

[including] high levels of cholesterol,” and has been prescribed statin drugs to control his 

cholesterol levels. See Am. Comp. at ¶¶10, 16. However, he complains that he is “highly 

intolerant to statin medications,” and “suffers from common side effects” including muscle 

cramps, joint pain, and fatigue. Id. at ¶17. To alleviate these side effects, Morrison states that 

prison medical staff previously prescribed him CoQ10. Id. at ¶¶19–20. This combination of 

statins and CoQ10 helped keep his cholesterol in the proper range and lessened the side effects 

he had previously experienced while on statins alone. Id. at ¶23. 

In 2017, Morrison was informed that CoQ10 could no longer be sold at inmate 

commissaries. Id. at ¶25. Nevertheless, as Morrison was transferred around the federal prison 

system, BOP approved his requests to maintain access to the supplement. See generally id. at 

¶¶30–37. In late 2018, however, Morrison’s authorization for CoQ10 expired and the “FBOP 

Central Office refused to approve” further requests for CoQ10 submitted by prison medical staff

on Morrison’s behalf. Id. at ¶¶38–40. According to medical records that Morrison attached to 

his Amended Complaint, BOP denied his requests for CoQ10 because, as a nutritional 

supplement, it is not FDA approved and it has not otherwise proven effective for the treatment of 

the types of conditions that Morrison reported to prison medical staff. Am. Comp. Ex. F at 1.

1

 

1 While typically restricted to the pleadings when deciding a motion to dismiss for failure 

to state a claim under Federal Rule of Civil Procedure 12(b)(6), a court may consider 

“documents attached as exhibits or incorporated by reference in the complaint.” Hinton v. Corr. 

Corp. of Am., 624 F. Supp. 2d 45, 46 (D.D.C. 2009) (internal quotation marks omitted); see also

Marshall v. Honeywell Technology Solutions, Inc., 536 F. Supp. 2d 59, 65 (D.D.C. 2008)

(“[W]here a document is referred to in the complaint and is central to the plaintiff's claim, such a 

document attached to the motion papers may be considered without converting the motion [to 

dismiss] to one for summary judgment.”) (internal quotation and citation omitted). Here,
3

Without the CoQ10, Morrison alleges that the side effects returned and he discontinued taking 

his statin medication. Id. at ¶41. Morrison attempted to take various statins in 2019 without 

CoQ10 but again experienced side effects and stopped taking them. See id. at ¶¶43–50. 

After filing his initial complaint in this case and due to his reported intolerance to statins, 

Morrison was prescribed Repatha, an injectable non-statin medication, with approval of BOP’s 

Central Office. Id. at ¶50; Am. Comp. Ex. G at 1. Morrison acknowledges that the Repatha 

injections lowered his cholesterol to normal levels. Am. Comp. at ¶50. Two months after 

beginning the treatments, however, Morrison reported to FCI Elkton medical staff that he was 

experiencing lower back pain, muscle aches, and plantar fasciitis, which he claims are side 

effects of the Repatha. Id. (citing Am. Comp. Ex. H.) Prison medical staff treated his pain with 

a steroid and provided him stretching exercises to relieve the reported plantar fasciitis. Am. 

Comp. Ex. H. at 1. Morrison also claims in the Amended Complaint that he developed “fatigue” 

and “unexplained nail fungus” as a result of taking Repatha, but there is no indication in the 

attached medical records (nor does the Amended Complaint allege) that he brought these issues 

to the attention of prison medical staff. Am. Comp. at ¶50.

Morrison seeks declaratory judgments that BOP “is obligated to provide adequate 

medical care to [p]laintiff while he is in [its] care, custody, and control,” that his “[h]igh levels of 

blood cholesterol [represent] a serious medical need,” and that he has a right to approval of his 

non-formulary requests for CoQ10 as part of the treatment for his high cholesterol. Id. at 12. 

The government has moved to dismiss Morrison’s suit for lack of subject matter jurisdiction due 

 

Morrison has attached eight sets of prison medical records as exhibits to his Amended 

Complaint, which the Court will consider in deciding the present motion. 
4

to mootness and for failure to state a claim. Alternatively, it seeks a transfer of venue to the 

Southern District of Ohio, where Morrison was housed when he filed suit.

II. Analysis

Morrison’s complaint does not cite a specific cause of action supporting his claim of 

mistreatment and is somewhat unclear as to the basis for his suit. See Am. Comp. at 1–12. The

Court will nonetheless construe his complaint liberally due to his pro se status. See, e.g.,

Sanchez-Mercedes v. Bureau of Prisons, 453 F. Supp. 3d 404, 415–16 (D.D.C. 2020). Because 

the relief Morrison requests is equitable and makes express reference to his “serious medical 

need[s]” (a phrase taken from Eighth Amendment caselaw), see Am. Comp. at 12, the Court 

construes Morrison’s complaint as seeking a declaratory judgment vindicating his Eighth 

Amendment right to be free from cruel and unusual punishment. So read, the Court has subject 

matter jurisdiction under 28 U.S.C. § 1331 as Morrison’s claim “aris[es] under the Constitution.” 

See Simmat v. U.S. Bureau of Prisons, 413 F.3d 1225, 1232 (10th Cir. 2005) (holding, in the 

context of an Eighth Amendment claim for equitable relief due to denial of medical treatment, 

that “Section 1331 [] provides jurisdiction for the exercise of the traditional powers of equity in 

actions arising under” the Eighth Amendment).

2

A. Mootness

The government moves to dismiss the action on the grounds that the suit is moot because 

Morrison is now receiving medication which keeps his cholesterol within normal levels. See

Mot. to Dismiss at 5–6. However, while Morrison’s initial complaint focused on the treatment of 

 

2 Morrison also correctly notes that the waiver of sovereign immunity in the 

Administrative Procedure Act, 5 U.S.C. § 702, would apply to such a suit. Simmat, 413 F.3d at 

1233; see also Chamber of Commerce v. Reich, 74 F.3d 1322, 1329 (D.C. Cir. 1996) (“The 

APA's waiver of sovereign immunity applies to any suit whether under the APA or not.”).
5

his high cholesterol, the Amended Complaint does not solely––or even primarily––concern his 

cholesterol levels. It rather focuses on the side effects he allegedly experiences as a result of his 

Repatha injections, side effects Morrison says would be absent were he provided access to 

CoQ10 in combination with statins. See Am. Comp. at ¶¶50–53. The government’s arguments 

regarding Morrison’s cholesterol levels are thus misplaced; the relevant harms are the purported 

Repatha side effects. As discussed below, these side effects may or may not be sufficiently 

serious to ground an Eighth Amendment claim, see infra II.C, but they are enough to save 

Morrison’s suit from mootness.

B. Venue

The government also moves to transfer venue to the Southern District of Ohio, arguing

that is where “Plaintiff can be found as well as where his medical records and witness may also 

be found.” Mot. to Dismiss at 8. However, Morrison’s central allegation is that the denial of his 

CoQ10 medication was a decision made by the “FBOP Central Office” located in Washington, 

D.C. See, e.g., id. at ¶29. Further, given that Morrison received treatment at various BOP 

facilities during the time period covered by the Amended Complaint, see, e.g., id. at ¶42, and has 

subsequently been relocated from Ohio to Oklahoma, see Notice of Change of Address, ECF. 

Dkt. No. 35, there is little to be gained in terms of convenience of the parties and witnesses by 

transferring this matter to Ohio. The Court therefore denies the government’s request to transfer 

venue.

C. Eighth Amendment Claim

To establish a claim under the Eighth Amendment for denial of adequate medical care

while incarcerated, a plaintiff must show that he suffered from a serious medical need and that 
6

prison officials were deliberately indifferent to that need. See Banks v. York, 515 F. Supp. 2d 

89, 102 (D.D.C. 2007); see also Estelle v. Gamble, 429 U.S. 97, 103–04 (1976). 

As to the first requirement, the D.C. Circuit has given little guidance on what a plaintiff 

must show to establish that he suffered from a serious medical need. See Woodruff v. United 

States, No. CV 16-1884 (RDM), 2020 WL 3297233, at *10 (D.D.C. June 18, 2020) (noting “the 

absence of controlling D.C. Circuit case law [] regarding what it means for a prisoner to have a 

‘serious medical need’”). Fellow district courts to have confronted the question have found a 

serious medical need where the prisoner is suffering from an ailment which the general public 

would easily recognize as demanding medical intervention, or, in some cases, where the ailment 

has been previously diagnosed and treated by a physician. See, e.g., Chandler v. Stover, 211 F. 

Supp. 3d 289, 301 (D.D.C. 2016) (“[a] medical need is serious if it is one that has been 

diagnosed by a physician as mandating treatment or one that is so obvious that even a lay person 

would easily recognize the necessity for a doctor's attention”). 

Morrison complains of muscle cramps, fatigue, and an unexplained nail fungus due to his 

Repatha injections. Am. Comp. at ¶50. The Court questions whether these conditions are 

sufficiently serious to ground an Eighth Amendment claim. See Roberson v. Manasrah, No. 

117CV01062DADSAB, 2019 WL 1517721, at *1 (E.D. Cal. Apr. 8, 2019) (dismissing Eighth 

Amendment claim for failure to show serious medical need where plaintiff “submitted forms 

complaining of shortness of breath, muscle cramping, chest pain, joint pain, severe headaches, 

night sweats, and coughing”); but see Merritte v. Arbuckle, No. 16-CV-0959-NJR, 2016 WL 

7174663, at *3 (S.D. Ill. Dec. 8, 2016) (Eighth Amendment claim permitted to proceed after 

plaintiff “experienced muscle cramps, hunger pains, migraines, and lethargy as a result of 

receiving meal trays with beans” to which he was allergic). The Court need not decide this issue, 
7

however, because it concludes that Morrison has failed to allege facts showing that BOP medical 

personnel acted with deliberate indifference to the purported side effects of the Repatha 

injections. 

Deliberate indifference in violation of the Eighth Amendment must “constitute[] 

unnecessary and wanton infliction of pain contrary to contemporary standards of decency.”

Helling v. McKinney, 509 U.S. 25, 32 (1993) (citing Estelle, 429 U.S. at 104). It is “a state of 

mind more blameworthy than negligence,” Farmer v. Brennan, 511 U.S. 825, 835 (1994), and 

more akin to “criminal recklessness,” Barr v. Pearson, 909 F.3d 919, 922 (8th Cir. 2018). As 

relevant here, “mere disagreement over the proper treatment” cannot support a finding of 

deliberate indifference. Banks, 515 F. Supp 2d at 103 (quoting Chance v. Armstrong, 143 F.3d 

698, 703 (2d. Cir. 1998)). 

Morrison has not met this demanding standard. As noted above, the documents attached 

to Morrison’s complaint attest that the prison medical personnel responsible for his care 

prescribed treatment for the main side effects from Repatha that Morrison reported to them. See

Am. Comp. Ex. H at 1 (prescribing an anti-inflammatory steroid for reported lower-back pain 

and muscle aches and providing Morrison with stretching exercises to relieve his plantar 

fasciitis). Where prison medical officials provide treatment for the medical issue in question, 

“‘[a] prisoner's mere difference of opinion over matters of expert medical judgment or a course 

of medical treatment’” does not amount to a showing of deliberate indifference on the part of the 

prison’s medical staff. Barr, 909 F.3d at 921–22 (quoting Meuir v. Greene Cty. Jail Emps., 487 

F.3d 1115, 1118–19 (8th Cir. 2007)); see also id. at 922 (finding no deliberate indifference where 

prison officials “continued to provide medical care” including “providing other medication” to 
8

treat an inmate after side effects caused medical officials to end a course of treatment the 

plaintiff favored).

3

 

Although the focus of Morrison’s claim is, as noted above, the side effects he currently 

experiences from Repatha, he similarly fails to allege facts showing that the BOP’s refusal to 

provide him with CoQ10 was the result of deliberate indifference. The medical records attached 

to Morrison’s complaint indicate that BOP officials refused this request because (1) there was 

“little published evidence showing benefit of [CoQ10] for the treatment of myopathy”4 and (2) 

BOP generally does not approve the use of nutritional supplements, which are not FDA 

approved. Am. Comp. Ex. F at 1. Moreover, Morrison acknowledges that BOP’s administration 

of Repatha as an alternative to statins and CoQ10 (and which was approved by the Central 

Office) was effective in lowering his cholesterol to normal levels. Am. Comp. at ¶50. 

Morrison’s disagreements with the medical judgments underlying both the refusal to provide him 

CoQ10 and the treatment provided for his Repatha-related side effects are thus insufficient to

show that BOP officials were deliberately indifferent to his medical needs. See Bryant v. 

Wright, 451 F. App’x. 12 (2d Cir. 2011) (finding no deliberate indifference where prescription of 

 

3 Although Morrison’s Amended Complaint alleges that he also suffers from an 

unexplained nail fungus, he does not allege––nor do the medical records attached to his 

complaint show––that prison medical staff were aware of this ailment. See Am. Comp. Ex. H at 

1. Absent such awareness, any failure to treat the fungus cannot show deliberate indifference. 

See Baker v. District of Columbia, 326 F.3d 1302, 1306 (D.C. Cir. 2003) (“To show deliberate 

indifference, [a plaintiff must] allege that [the defendant] had subjective knowledge of [a] serious 

medical need and recklessly disregarded the excessive risk to inmate health or safety from that 

risk.” (emphasis added)). As for Morrison’s unspecific complaints of “fatigue,” a prison doctor's 

refusal to “dispense bromides for the sniffles or minor aches and pains or a tiny scratch or a mild 

headache or minor fatigue . . . does not violate the Constitution.” Cooper v. Casey, 97 F.3d 914, 

916 (7th Cir.1996). 

4 “Myopathy” is a general term that encompasses the muscle pain and cramping that 

Morrison reported to FCI Elkton medical staff per the attached records.
9

generic medications caused inmate to suffer side effects because choice of medication was a

common exercise of judgment and doctors worked to treat the side effects). 

Finally, in the rare cases where courts have entertained Eighth Amendment claims arising 

from the alleged insufficiency of a physician’s choice of treatment, they have required plaintiffs

to allege facts showing a more culpable mental state than that associated with merely “‘fail[ing] 

to provide the [allegedly] more efficacious treatment.’” See Banks, 515 F. Supp. 2d at 103 

(quoting O’Connor v. McArdle, 217 F. App’x. 81, 83 (2d Cir. 2007)); see also id. (noting that 

cases where plaintiffs successfully maintain a claim for deliberate indifference based on the 

purported shortcomings of the treatment received require the plaintiffs to allege, e.g., financial 

motives or other suspect incentives behind the physician’s choice of treatment). Morrison’s 

complaint does not in any way suggest that BOP’s treatment of his high cholesterol or the 

Repatha side effects emerged from any such improper motive or culpable mental state. See Am. 

Comp. at 1–12. He thus cannot maintain a suit for an Eighth Amendment violation based on his 

dissatisfaction with the course of treatment chosen or approved by BOP personnel. 

III. Conclusion

For the foregoing reasons, the Court will grant [28] Defendant’s Motion to Dismiss for 

failure to state a claim on which relief can be granted. A separate order will follow.

CHRISTOPHER R. COOPER

United States District Judge

Date: March 30, 2021